DLD Asset Management, LP
Source: SEC Form 13F · as of Mar 2026DLD Asset Management, LP holds 15 biotech & pharma companies tracked by BioSniper, totaling $17.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
15
Total value held
$17.4M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Inhibrx Biosciences, Inc. (INBX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| INBXInhibrx Biosciences, Inc. | 68,400 | $4.6M |
| TERNTerns Pharmaceuticals, Inc. | 47,025 | $2.5M |
| IPEXInflection Point Acquisition Corp. V | 200,000 | $2.1M |
| REPLReplimune Group, Inc. | 242,600 | $1.9M |
| ZYMEZymeworks Inc. | 53,000 | $1.3M |
| EWTXEdgewise Therapeutics, Inc. | 31,100 | $979K |
| CCXIChemoCentryx, Inc. | 78,804 | $801K |
| AVTXAvalo Therapeutics, Inc. | 49,500 | $743K |
| CMPSCOMPASS Pathways plc | 107,600 | $595K |
| UTHRUNITED THERAPEUTICS Corp | 1,000 | $593K |
| CYTKCYTOKINETICS INC | 7,500 | $494K |
| SLNOSOLENO THERAPEUTICS INC | 10,000 | $335K |
| RZLTRezolute, Inc. | 100,000 | $304K |
| VIRVir Biotechnology, Inc. | 15,000 | $134K |
| ATAIAtai Beckley N.V. | 33,600 | $119K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.